Weller, M

A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. [electronic resource] - Medical hypotheses Aug 1992 - 329-33 p. digital

Publication Type: Journal Article

0306-9877

10.1016/0306-9877(92)90027-a doi


Amantadine--therapeutic use
Humans
Models, Biological
Muscle Spasticity--drug therapy
Neuroleptic Malignant Syndrome--drug therapy
Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors
Synaptic Transmission--drug effects